ArticleDrugs in context2025

Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study.

Federico Sottotetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.